NFKB1 and cancer: Notably, PLTs have achieved extensive application in the treatment of cancer and inflammatory disorders via modulating key signaling pathways, including NF-κB, STAT3, and MAPK, which are essential to both oncogenic progression and the regulation of immune responses.